Company Information
Amyloid Solution Inc. is a novel science-based preclinical stage biotech developing disease-modifying treatments for Alzheimer’s Disease. Amyloid Solution focuses on a comprehensive understanding of Alzheimer's disease and a concomitant approach, focusing on two core mechanisms. (1) AMYLOID: Focus on developing oral drugs to disaggregate beta amyloid oligomers/fibrils or misfolded tau proteins. (2) GLIA : Focus on finding new features and novel targets for astrocyte and microglia. In addition, we hope to advance the drug delivery platform and the discovery research in a long-term perspective.
